Four Decades of History & Evolution of Clinical Pharmacology at US Food and Drug Administration (FDA)—Part II: Dose Individualization and Approvability Evidence

Mehul Mehta

Open source

DOI
10.1208/s12248-026-01309-9
Published
2026-09-11
Container
The AAPS Journal
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1208/s12248-026-01309-9,
  title = {Four Decades of History \& Evolution of Clinical Pharmacology at US Food and Drug Administration (FDA)—Part II: Dose Individualization and Approvability Evidence},
  author = {Mehul Mehta},
  year = {2026},
  journal = {The AAPS Journal},
  doi = {10.1208/s12248-026-01309-9},
  url = {https://doi.org/10.1208/s12248-026-01309-9}
}

RIS

TY  - JOUR
TI  - Four Decades of History & Evolution of Clinical Pharmacology at US Food and Drug Administration (FDA)—Part II: Dose Individualization and Approvability Evidence
AU  - Mehul Mehta
PY  - 2026
JO  - The AAPS Journal
DO  - 10.1208/s12248-026-01309-9
UR  - https://doi.org/10.1208/s12248-026-01309-9
ER  - 

APA

Mehta, M. (2026). Four Decades of History & Evolution of Clinical Pharmacology at US Food and Drug Administration (FDA)—Part II: Dose Individualization and Approvability Evidence. The AAPS Journal. https://doi.org/10.1208/s12248-026-01309-9

Source records